Thomas Beyer Selected Research

Arthroplasty

1/2022

Elective transfemoral amputation and simultaneous implantation of a transcutaneous osseointegrated prosthesis stem as salvage treatment after knee joint arthrodesis with poor function: A case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Beyer Research Topics

Disease

17	Neoplasms (Cancer) 01/2023 - 11/2003
3	Epilepsy (Aura) 06/2023 - 01/2020
3	Breast Neoplasms (Breast Cancer) 03/2021 - 11/2003
2	Prostatic Neoplasms (Prostate Cancer) 09/2023 - 01/2023
2	Glioma (Gliomas) 01/2023 - 01/2018
2	Atherosclerotic Plaque (Atheroma) 01/2022 - 07/2016
2	Osteoid Osteoma 08/2019 - 08/2019
2	Osteoblastoma 08/2019 - 08/2019
2	Inflammation (Inflammations) 01/2018 - 01/2017
2	Meningioma (Meningiomas) 01/2013 - 09/2011
2	Acquired Immunodeficiency Syndrome (AIDS) 05/2011 - 02/2011
2	Head and Neck Neoplasms (Head and Neck Cancer) 07/2008 - 09/2007
2	Lung Neoplasms (Lung Cancer) 03/2008 - 07/2007
1	Squamous Cell Carcinoma of Head and Neck 01/2023
1	Pain (Aches) 01/2022
1	Rupture 01/2022
1	Chronic Pain 01/2018
1	Infections 01/2018
1	Brain Neoplasms (Brain Tumor) 01/2017
1	Atherosclerosis 01/2017
1	Body Weight (Weight, Body) 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2013
1	Insulin Resistance 10/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2011
1	Neoplasm Metastasis (Metastasis) 02/2010
1	Solitary Pulmonary Nodule 01/2010
1	Thyroid Diseases (Thyroid Disease) 01/2009
1	Dyskinesias (Dyskinesia) 11/2002

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2013
5	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2022 - 01/2004
5	AntibodiesIBA 07/2012 - 03/2008
5	ErbB Receptors (EGF Receptor)IBA 03/2011 - 09/2007
3	Edotreotide (SMT 487)IBA 01/2013 - 05/2011
3	Immunoglobulin A (IgA)IBA 07/2012 - 09/2007
2	Amino Acids FDA Link 01/2023 - 01/2018
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 01/2018
2	Monoclonal AntibodiesIBA 08/2010 - 07/2008
2	Complement System Proteins (Complement)IBA 08/2010 - 07/2008
2	Epidermal Growth Factor (EGF)IBA 08/2010 - 09/2007
1	Methionine (L-Methionine)FDA Link 01/2023
1	Genetic Markers (Genetic Marker)IBA 01/2023
1	LigandsIBA 01/2023
1	Opioid Analgesics (Opioids)IBA 01/2022
1	68Ga-pentixaforIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2020
1	antineoplaston A10 (A 10)IBA 05/2019
1	Nucleic AcidsIBA 01/2018
1	68Ga-DOTANOCIBA 01/2017
1	Adenosine Diphosphate (ADP)IBA 01/2016
1	SphingolipidsIBA 10/2011
1	SphingomyelinsIBA 10/2011
1	SirtuinsIBA 02/2010
1	zalutumumabIBA 01/2010
1	Fc gamma receptor IIAIBA 01/2010
1	Panitumumab (Vectibix)FDA Link 01/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2010
1	Phosphotransferases (Kinase)IBA 03/2008
1	Tyrosine Kinase InhibitorsIBA 03/2008
1	Immunoglobulin G (IgG)IBA 09/2007
1	Therapeutic UsesIBA 09/2007
1	Mannitol (Osmitrol)FDA LinkGeneric 03/2004
1	BariumIBA 03/2004
1	Contrast MediaIBA 01/2004
1	Keratin-18 (Keratin 18)IBA 11/2003

Therapy/Procedure

7	Therapeutics 01/2023 - 07/2007
5	Radiotherapy 01/2013 - 06/2004
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 11/2013 - 09/2011
3	Patient Positioning 05/2011 - 11/2002
2	Precision Medicine 01/2023 - 04/2020
2	Radiofrequency Ablation 08/2019 - 08/2019
2	Immunotherapy 07/2012 - 11/2003
2	Drug Therapy (Chemotherapy) 07/2007 - 06/2004
1	Prostatectomy (Retropubic Prostatectomy) 09/2023
1	Drug Tapering 06/2023
1	Arthrodesis 01/2022
1	Surgical Amputation (Amputations) 01/2022
1	Arthroplasty 01/2022
1	Imaging Phantoms 04/2020
1	Surgical Instruments (Clip) 01/2010
1	Catheters 01/2010
1	CT protocol 07/2007
1	Oral Administration 03/2004
1	Lasers (Laser) 11/2003